Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Feng

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
JCO Clinical Cancer Informatics|November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerDaniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
The Lancet. Oncology|November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
The Journal of Pathology|December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimensBrennan T Flannery, Howard M Sandler, Priti Lal, et al.
JCO Precision Oncology|July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion SequencingEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Scientific Reports|March 4, 2021
Cell-free DNA concentration and fragment size as a biomarker for prostate cancerEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
The Prostate|July 21, 2025
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following ProstatectomyEmily Chan, Stephanie L Pugh, Jeffry P Simko, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
JCO Clinical Cancer Informatics|November 21, 2025
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerDaniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, et al.
The Lancet. Oncology|November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
The Journal of Pathology|December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimensBrennan T Flannery, Howard M Sandler, Priti Lal, et al.
JCO Precision Oncology|July 12, 2021
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion SequencingEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Scientific Reports|March 4, 2021
Cell-free DNA concentration and fragment size as a biomarker for prostate cancerEmmalyn Chen, Clinton L Cario, Lancelote Leong, et al.
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
The Prostate|July 21, 2025
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following ProstatectomyEmily Chan, Stephanie L Pugh, Jeffry P Simko, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Pageof 8